Comparison of the I-gel Laryngeal Mask and the Classic Laryngeal Mask in Patients With a BMI>25
NCT ID: NCT01003327
Last Updated: 2010-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
50 participants
INTERVENTIONAL
2009-10-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laryngeal Mask Supreme™ Versus the I-gel™
NCT00653237
Comparison of Laryngeal Mask and I-gel to Laryngoscope by Novice Operators in Simulated Difficult Airway
NCT02224027
Randomized Comparative Study Between Classic Laryngeal Mask Airway and I Gel Airway in Obese Patients Having BMI 35-40 During Elective Non Abdominal Surgery.
NCT03843827
Comparison of Two Type of Laryngeal Mask : I-Gel & LMA ProSeal
NCT00624403
Comparison Study of Two Supraglottic Airway Devices Used for Patients Under General Anesthesia
NCT01001078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For statistical analysis we will use t-tests with a power of 80% and a p \< 0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I-gel inserted first
The I-gel airway is insewrted first, then the LMA-Unique
I-gel
intubation with I-gel airway
LMA-Unique inserted first
LMA-Unique airway is inserted first, then the I-gel
LMA-Unique
LMA-Unique airway is inserted first, then the I-gel
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
I-gel
intubation with I-gel airway
LMA-Unique
LMA-Unique airway is inserted first, then the I-gel
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \> 18 years,
* ASA I-II;
Exclusion Criteria
* history of reflux or gastrointestinal disorders,
* abdominal or thoracic surgery;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Medical University of Vienna
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulrike Weber, M.D.
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical university of vienna, General hospital of Vienna
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
354/2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.